Skip to main content
Clinical Trials/NCT03830450
NCT03830450
Unknown
Not Applicable

Biomarkers in Estimation for Risk of Acute Kidney Injury in Cardiac Surgery

Nikola Bradic, MD0 sites50 target enrollmentDecember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury (Nontraumatic)
Sponsor
Nikola Bradic, MD
Enrollment
50
Primary Endpoint
Consecutive values of neutrophil gelatinase-associated lipocalin (NGAL)
Last Updated
5 years ago

Overview

Brief Summary

Acute kidney injury (AKI) is the most common complication in patients after cardiac surgery. An usual estimation of risk for AKI is estimation of serum creatinine, which is unreliable indicator of AKI risk. Because of that, today different biomarkers are investigated to predict incidence for development AKI after cardiac surgery. This investigation will try to find potentially risk patients for developing AKI after cardiac surgery by using conventional markers (creatinine, glomerular filtration rate) in perioperative period comparing with two different biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and growth differentiation factor 15 (GDF-15) which are proven markers in patients with increased risk for AKI development.

Registry
clinicaltrials.gov
Start Date
December 1, 2020
End Date
December 31, 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Nikola Bradic, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Nikola Bradic, MD

MD, Senior Lecturer

University Hospital Dubrava

Eligibility Criteria

Inclusion Criteria

  • patients scheduled for cardiac surgery (CABG, valve replacement/repair, combined)
  • older than 18 years

Exclusion Criteria

  • previous known renal disease
  • patients on chronic dialysis

Outcomes

Primary Outcomes

Consecutive values of neutrophil gelatinase-associated lipocalin (NGAL)

Time Frame: One year

By the changing of NGAL values in consecutive measuring, predict which patients are in increased risk for development of AKI

Consecutive values of growth differentiation factor 15 (GDF-15)

Time Frame: One year

By the changing of GDF-15 values in consecutive measuring, predict which patients are in increased risk for development of AKI

Consecutive values of glomerular filtration rate (GFR)

Time Frame: One Year

By the changing of GFR values in consecutive measuring, predict which patients are in increased risk for development of AKI

Similar Trials